Recent improvements in the diagnosis and treatment of testicular cancer mean that most men – especially those diagnosed with an early-stage tumor – can expect to survive the disease.(1) According to the National Cancer Institute, 95 percent of all men with newly diagnosed testicular cancer survive at least five years after treatment, thanks in large part to the availability of highly effective chemotherapy drugs.
Studies have shown that men with advanced testicular cancer have better outcomes at centers that treat more patients with the disease.(2) Doctors at Memorial Sloan-Kettering’s Sidney Kimmel Center for Prostate and Urologic Cancers are among the most experienced in this field, treating 250 to 300 men who are newly diagnosed with testicular cancer each year.
Our multidisciplinary testicular cancer team includes specialists in urology, surgery, radiation oncology, medical oncology, and pathology. Your particular team of experts will use sophisticated imaging and laboratory tests to confirm your diagnosis and identify the characteristics of your tumor. They will then work together to develop an individualized treatment plan, with the goal of eliminating your cancer.
We understand that going through testicular cancer treatment can be difficult, especially for young men who are otherwise healthy. In some cases, testicular cancer therapy can affect sperm production or ejaculation, leading to infertility. Memorial Sloan-Kettering has a dedicated team of nurses and doctors that can help you manage all of these side effects, including those related to sexual health. Experts in our Male Sexual and Reproductive Medicine Program can also counsel you about storing sperm prior to treatment.
Learn about how we diagnose and treat testicular cancer.